Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Latest Information Update: 12 Dec 2022
At a glance
- Drugs Ilodecakin (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Acronyms ARTIST 1; Sequoia
- Sponsors ARMO Biosciences; Eli Lilly and Company
- 08 Feb 2021 Interim results (data cut off date - September 9, 2019) published in the Journal of Clinical Oncology.
- 21 Apr 2020 Status changed from active, no longer recruiting to completed.
- 01 Mar 2020 This trial has been completed in Spain, according to European Clinical Trials Database record.